Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 4Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

pembrolizumab 11Nivolumab 6fludarabine phosphate 5fludarabine 5Paclitaxel 5Cisplatin 5Cetuximab 5Carboplatin 5atezolizumab 4Pemetrexed 4Docetaxel 4Cyclophosphamide 4Bevacizumab 4durvalumab 3Specimen Handling 3Magnetic Resonance Spectroscopy 3Ipilimumab 3venetoclax 2ibrutinib 2enzalutamide 2encorafenib 2binimetinib 2Trastuzumab 2Taxes 2Standard of Care 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Practice Guidelines as Topic 2Platinum 2Oxaliplatin 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × gallium 68 PSMA-11 × 30 days × Clear all
NCT04716725 2026-05-15

68Ga-PSMA-11 PET for the Diagnosis of Metastatic Castration Resistant Prostate Cancer

University of California, San Francisco

Phase 2 Terminated
15 enrolled 10 charts
Genitourinary

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡